MONICA DENZ: Open Payments
NPI 1972145449 · DEPEW, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$198 in 9 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $433 · 2025 $198
Food & beverage: $198
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 1 | $28 |
| Dexcom, Inc. | 1 | $27 |
| Lilly USA, LLC | 1 | $23 |
| Exact Sciences Corporation | 1 | $22 |
| MILLICENT US INC | 1 | $22 |
| Astellas Pharma US Inc | 1 | $21 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $20 |
| Novo Nordisk Inc | 1 | $18 |
| Amgen Inc. | 1 | $17 |
Products named: MYFEMBREE, Dexcom G6 Transmitter, MOUNJARO, Cologuard Collection Kit, FEMLYV, Veozah, JOURNAVX, EVENITY.
Industry payments across NY — which companies pay providers there.
